Medical Malpractice · Full chronicle and history

On November 7, the Sichuan Provincial Communications Hospital reported that on the 4th, a sodium chloride injection with an expiration date of August 27 was mistakenly used during a patient's IV infusion. The infusion was stopped and an examination was arranged; the patient showed no abnormalities. Both parties signed a settlement agreement on the 6th. The hospital disciplined the responsible nurse, the head nurse, and nursing management personnel, and reported the incident to the health and drug regulatory departments.

During the patient's hospitalization, the hospital claimed they had no gastric tubes and required the family to purchase one themselves. Overnight, the patient's intestinal obstruction developed into diffuse peritonitis, constituting a medical malpractice case.

Guoguo, a 3-month-and-18-day-old infant, was admitted to the Tongzhou branch of Beijing Anzhen Hospital on October 12 for a congenital ventricular septal defect. The surgery was originally expected to take 4 hours but lasted about 18 hours. The next morning, the family received a notice of death without having received a critical condition notice. The cause of death remains unexplained, and an autopsy is currently underway.

On October 8, a netizen revealed that the ceilings and walls of wards in the inpatient building at the Xiashan Campus of Guangdong Medical University Affiliated Hospital in Guangdong were blackened over large areas and covered with mildew. The hospital confirmed the mold problem, saying it had transferred patients to normal wards.

Circulating online on September 6, 2026, a submission from a patient's family reported that a serious medical accident occurred at Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, accusing the doctor involved of carrying out medical orders incorrectly and tampering with medical record data, which left the child paralyzed and then dead.

On August 5, 2026, under continued media questioning, the pharmaceutical company involved confirmed that a boy in a gene-editing trial at Shanghai Children's Medical Center died in August 2025 from a serious adverse reaction, after the parties involved had concealed the information and not made it public.

On July 27, 2026, regarding the death of a 6-year-old girl at Shanghai Xinhua Hospital after receiving experimental gene-editing treatment, staff from the Yangpu District Health Commission of Shanghai told media that relevant departments had stepped in to investigate.

On July 26, 2026, the School of Medicine of Shanghai Jiao Tong University issued a statement saying that a special task force had been set up to conduct a comprehensive investigation into reports about gene-editing clinical research at Xinhua Hospital, and that action would be taken seriously based on the results.

On the evening of May 26, 2026, following a tip, reporters conducted an undercover visit to a villa on Wuzhou Road in Linping District, Hangzhou, and found that it had illegally set up an underground test-tube baby laboratory without any medical qualifications, carrying out egg donation, embryo cultivation and transplant procedures in violation of regulations.

Science magazine revealed in July 2026 that in March 2025 a 6-year-old girl received gene editing treatment at Shanghai Xinhua Hospital and died of a severe immune response 7 days after the virus was injected into her cerebrospinal fluid.